Victor Peperzak

8PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Gene and molecular therapyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 19, 2025
Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation.

Thomas Kimman, Marta Cuenca, Ralph G Tieland

|Feb 26, 2024
Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient-derived in vitro model.

Niels van Nieuwenhuijzen, Marta Cuenca, Leonie Abbink

|Sep 13, 2023
Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-XL in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.

Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Rosana Díez

|Mar 17, 2023
Serpin B9 controls tumor cell killing by CAR T cells.

Thomas Kimman, Anne Slomp, Anne Martens

|Dec 14, 2021
Inhibitory pattern recognition receptors.

Matevž Rumpret, Helen J von Richthofen, Victor Peperzak

|May 20, 2018
Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.

Ingrid Spaan, Reinier A Raymakers, Anja van de Stolpe

Pageof 2

Frequent Collaborators

3 joint publications

Jurgen Kuball

3 joint publications

Marta Cuenca

2 joint publications

Joost P G Sluijter

2 joint publications

Douwe Mt Bosma